VENTUS THERAPEUTICS
Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus' structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system.
VENTUS THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.ventustx.com
Total Employee:
51+
Status:
Active
Contact:
514-397-9517
Email Addresses:
[email protected]
Total Funding:
300 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
FogPharma
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
Andreessen Horowitz
Andreessen Horowitz investment in Series C - Ventus Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Ventus Therapeutics
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Ventus Therapeutics
Versant Ventures
Versant Ventures investment in Series C - Ventus Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Ventus Therapeutics
Fonds de solidaritรฉ FTQ
Fonds de solidaritรฉ FTQ investment in Series C - Ventus Therapeutics
Casdin Capital
Casdin Capital investment in Series C - Ventus Therapeutics
BVF Partners
BVF Partners investment in Series C - Ventus Therapeutics
GV
GV investment in Series C - Ventus Therapeutics
Qatar Investment Authority
Qatar Investment Authority investment in Series C - Ventus Therapeutics
Key Employee Changes
Official Site Inspections
http://www.ventustx.com Semrush global rank: 5.09 M Semrush visits lastest month: 1.61 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago